Understanding and reducing suicidal behavior in bipolar disorder patients
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder: The Roles of Biological and Childhood and Adult Environmental Risk Factors
This study is testing a 6-week group program with different therapies to see if it can help people with bipolar disorder reduce suicidal thoughts and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 130 (estimated) |
| Ages | 18 Years to 64 Years |
| Sex | All |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Trial ID | NCT02604277 on ClinicalTrials.gov |
What this trial studies
This study investigates the environmental and psychological factors influencing suicidality in individuals diagnosed with Bipolar Disorder. It aims to identify effective treatments to reduce suicidal behavior and enhance quality of life through a 6-week group-based intervention program. The program includes various therapeutic approaches such as Interpersonal and Social Rhythm Therapy, Bipolar-Specific Cognitive Behavioral Therapy, and Mindfulness-Based Stress Reduction, focusing on coping strategies and understanding bipolar disorder.
Who should consider this trial
Good fit: Ideal candidates for this study are English-speaking individuals diagnosed with Bipolar Disorder who can provide informed consent.
Not a fit: Patients with cognitive impairments, acute psychosis, or a history of schizophrenia spectrum disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies that significantly reduce suicidal behavior in patients with Bipolar Disorder.
How similar studies have performed: Other studies have shown promise in using similar therapeutic approaches to address suicidality in bipolar disorder, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * English speaking * Diagnosis of Bipolar Disorder (BD) * Able to provide written informed consent Exclusion Criteria: * Cognitive impairments * Acutely psychotic * Medically unstable * History of schizophrenia spectrum disorder * History of mood incongruent psychotic symptoms * History of primary substance disorder * History of primary organic disease and/or dementia
Where this trial is running
Atlanta, Georgia
- Grady Health System — Atlanta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: Dorian Lamis, PhD — Emory University
- Study coordinator: Dorian Lamis, PhD
- Email: dorian.lamis@emory.edu
- Phone: (404) 616-3533
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.